Protalix Biotherapeutics, Inc.
PLX
Revenue
18.22M
▲259.00k▲1.44%
3 Months ChangeAssets
73.42M
▲11.85M▲19.26%
3 Months ChangeLiabilities
30.21M
▲1.08M▲3.71%
3 Months ChangeFree Cash Flow
3.59M
▲6.84M▲210.60%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-25
Form 8-K
ID: 0001558370-24-013664
2024-08-14
Form 10-Q
ID: 0001558370-24-012134
2024-08-14
Form 8-K
ID: 0001558370-24-012133
2024-06-28
Form 8-K
ID: 0001558370-24-009567
2024-05-10
Form 10-Q
ID: 0001558370-24-007695
2024-05-10
Form 8-K
ID: 0001558370-24-007692
2024-03-14
Form 8-K
ID: 0001558370-24-003160
2023-12-26
Form 8-K
ID: 0001558370-23-020006
2023-11-06
Form 10-Q
ID: 0001558370-23-017664
2023-11-06
Form 8-K
ID: 0001558370-23-017657